Results 71 to 80 of about 1,153,662 (221)

GC-MS analysis, evaluation of phytochemicals, anti-oxidant, thrombolytic and anti-inflammatory activities of Exacum bicolor

Bangladesh Journal of Pharmacology, 2015
The aim of the present study was to investigate the GC-MS analysis, phytochemical screening, anti-oxidant, thrombolytic and anti-inflammatory activities of methanol extract of leaves of Exacum bicolor.
Appaji Mahesh Ashwini, Latha Puttarudrappa, Belagumba Vijaykumar Ravi, Mala Majumdar   +3 more
doaj   +1 more source

Utility of the SWAM (Separator With Aspirator for Mechanical Thrombectomy) Device in Managing Hemodialysis Access Thrombosis

Hemodialysis International, EarlyView.
ABSTRACT Background Hemodialysis access thrombosis is the primary cause of access failure. Thrombus removal is an effective strategy to restore access function. Although both open surgical and endovascular procedures enable thrombus clearance, endovascular thrombus reduction therapy is widely adopted in clinical practice for this condition due to its ...
Lin Li, Zhongwang Zhang, Hongjie Wang, Mingdi Zhu, Kun Wang, Zheng Liu   +5 more
wiley   +1 more source

Comparative Analysis of Therapeutic Efficacy and Adverse Reactions among Various Thrombolytic Agents

Toxics
Thrombosis is a major health concern that contributes to the development of several cardiovascular diseases and a significant number of fatalities worldwide.
Chenxi Xie, Naying Zheng, Mingmei Li, Zhiyang Zhang, Dongqin Huang, Meizhu Xiao, Dongdong Chen, Chengyong He, Zhenghong Zuo, Xintan Chen   +9 more
doaj   +1 more source

Thrombolytic effects of Douchi Fibrinolytic enzyme from Bacillus subtilis LD-8547 in vitro and in vivo

BMC Biotechnology, 2012
Background Today, thrombosis is one of the most widely occurring diseases in modern life. Drugs with thrombolytic functions are the most effective methods in the treatment of thrombosis.
Yuan Jun, Yang Jing, Zhuang Zhenhong, Yang Yanling, Lin Ling, Wang Shihua   +5 more
doaj   +1 more source

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, restores blood–brain barrier integrity in a human stem cell‐based model of ischaemic stroke

British Journal of Pharmacology, Volume 183, Issue 19, Page 5791-5812, October 2026.
Ischaemic stroke is characterised by acute cerebrovascular occlusion and blood–brain barrier (BBB) breakdown. Our results indicated that the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) ameliorated the loss of BBB integrity, changed the morphology of brain endothelial cells, increased the level of basement membrane and ...
Anikó Szecskó, Koppány Párdi, Zuhao Cui, Gergő Porkoláb, Zsófia Hoyk, Csilla Kovács, Janet F. Adegbite, Virág Fodor, Nárcisz M. Cser, László Dér, Krisztina Nagy, Csilla Sajben, Roland Tengölics, Mária A. Deli, Szilvia Veszelka   +14 more
wiley   +1 more source

Ching Wah Silk Filature Coy. : French style

, 1894
Item title.An advertisment in English.Shingtoze Agent, issuing ...
Shingtoze Agent
core  

Clinical profile and mortality of ST-Segment elevation myocardial- infarction patients receiving thrombolytic -Therapy in the Middle East

Heart Views, 2012
Objective: Little is known about thrombolytic therapy patterns in patients with ST-elevation myocardial infarction (STEMI) in the Middle East. The objective of this study was to evaluate the clinical profile and mortality of STEMI patients who arrived in
Prashanth Panduranga, Ibrahim Al-Zakwani, Kadhim Sulaiman, Khalid Al-Habib, Jassim Al Suwaidi, Ahmed Al-Motarreb, Alawi Alsheikh-Ali, Shukri Al Saif, Hussam Al Faleh, Wael Almahmeed, Nidal Asaad, Haitham Amin, Jawad Al-Lawati, Ahmad Hersi   +13 more
doaj   +1 more source

Thrombolytics, Anticoagulants, and Antiplatelet Agents [PDF]

Stroke, 2006
More than 250 articles regarding thrombolytic therapy in acute ischemic stroke were published in the first 10 months of 2005 (Source PubMed). In this section we will focus on some reports that directly affect and improve the treatment of stroke patients, that led to further phase III trials, or that represent a great disappointment after several years ...
openaire   +2 more sources

Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future? [PDF]

Curr Treat Options Neurol, 2022
Mahmood A, Muir KW.
europepmc   +1 more source

Angiography‐Based Index of Microcirculatory Resistance in Assessing the MVO and Infarct Size in STEMI Patients

Clinical Cardiology, Volume 49, Issue 9, September 2026.
Angio‐IMR in Assessing CMD in STEMI Patients. A study of 123 OPTIMA‐5 STEMI patients found that a single bolus of half‐dose r‐SAK before primary PCI may help to improve post‐PCI angio‐IMR and reduce MVO and IS. Post‐PCI angio‐IMR also exhibited moderate diagnostic accuracy for MVO, MVO > 2.6%, and IS > 25%.
Tian Wu, Xiaojiao Zhang, Chen Li, Yumeng Hu, Mengying Dong, Jiaqi Chai, Inam Ullah, Han Xu, Pengsheng Chen, Huiping Xu, Xiaoru Cheng, Xiaoxuan Gong, Wei Li, Jianping Xiang, Ruina Hao, Chunjian Li   +15 more
wiley   +1 more source